Reading Time: 2 minutesIntroduction The advent of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has marked a significant advancement in the management of type 2 diabetes. Its efficacy in glycemic control and weight management has been well-documented. However, the integration of continuous glucose …